VIPoma natural history, complications and prognosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
==Natural History== | ==Natural History== | ||
*If left untreated, patients with VIPoma may progress to develop | |||
*VIpoma have a very slow growth rate compared to most malignant tumors. | |||
==Complications== | ==Complications== | ||
* [[Metastasis]] | * [[Metastasis]] | ||
Revision as of 14:43, 19 October 2015
|
VIPoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
VIPoma natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of VIPoma natural history, complications and prognosis |
|
VIPoma natural history, complications and prognosis in the news |
|
Blogs on VIPoma natural history, complications and prognosis |
|
Risk calculators and risk factors for VIPoma natural history, complications and prognosis |
{CMG}}Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [1]
Overview
Natural History
- If left untreated, patients with VIPoma may progress to develop
- VIpoma have a very slow growth rate compared to most malignant tumors.
Complications
- Metastasis
- Cardiac arrest from low blood potassium level
- Dehydration
Prognosis
- Surgery can usually cure VIPomas. However, in one-third to one-half of patients, the tumor has spread by the time of diagnosis and cannot be cured.
- VIPoma is associated with a 5 year survival rate of 20% and 3 year survival rate of 40%.[1]
References
- ↑ Smith, Stephen L.; Branton, Susan A.; Avino, Anthony J.; Martin, J.Kirk; Klingler, Paul J.; Thompson, Geoffrey B.; Grant, Clive S.; van Heerden, Jon A. (1998). "Vasoactive intestinal polypeptide secreting islet cell tumors: A 15-year experience and review of the literature". Surgery. 124 (6): 1050–1055. doi:10.1067/msy.1998.92005. ISSN 0039-6060.